Aytu BioPharma Reports Fiscal 2025 Full Year and Fourth Quarter Operational and Financial Results and Outlines Commercial Launch Plans for EXXUA(TM)
Stock Information for Eventide Small Cap ETF
Loading
Please wait while we load your information from QuoteMedia.